GLP1R and type 2 diabetes mellitus: Taken together, our findings suggest a potential protective association between GLP-1 RA therapy and attenuation of ascending aortic dilatation in T2DM; however, these results should be regarded as hypothesis-generating and require confirmation in larger multicenter randomized trials before any implications for clinical guidelines can be drawn.